Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.55 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.55 |
| ▸ | YARS1 | P54577 | 2/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31031588 | 0.96 | SLC7A5 (0.56) | SLC7A5OPRD1OPRM1YARS1 | |
| SCHEMBL30423707 | 0.95 | OPRM1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30622026 | 0.95 | SLC7A5 (0.61) | SLC7A5OPRD1ENPEPOPRM1YARS1 | |
| SCHEMBL9852121 | 0.95 | SLC7A5 (0.61) | SLC7A5OPRD1ENPEPOPRM1YARS1 | |
| SCHEMBL9852111 | 0.95 | SLC7A5 (0.61) | SLC7A5OPRD1ENPEPOPRM1YARS1 | |
| SCHEMBL29619568 | 0.93 | ENPEP (0.56) | SLC7A5OPRD1ENPEPOPRM1YARS1 | |
| SCHEMBL30123104 | 0.93 | ENPEP (0.56) | SLC7A5OPRD1ENPEPOPRM1YARS1 | |
| SCHEMBL30324823 | 0.92 | MME (0.60) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30839491 | 0.92 | MME (0.53) | SLC7A5OPRD1ENPEPOPRM1 | |
| SCHEMBL678158 | 0.92 | SLC7A5 (0.61) | SLC7A5OPRD1ENPEPOPRM1YARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083949-A1 | CELL PENETRATING PEPTIDE COMPOSITIONS AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-03-14 | — | — | US | claimed |
| US-20240083949-A1 | CELL PENETRATING PEPTIDE COMPOSITIONS AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083949-A1 | CELL PENETRATING PEPTIDE COMPOSITIONS AND METHODS THEREOF | VIP, IAPP, ANXA5 | SLC7A5 788/4885OPRD1 4341/4885ENPEP 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.